Human Molecular Genetics Advance Access published online on July 27, 2005
Human Molecular Genetics, doi:10.1093/hmg/ddi291
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institut National de la Santé et de la Recherche Médicale (INSERM Unité 551, «Dyslipoproteinemia and Atherosclerosis»)
* To whom correspondence should be addressed. Cholesteryl ester transfer protein (CETP) plays a key role in the determination of HDL levels via its action on intravascular HDL metabolism. The TaqIB polymorphism of the CETP gene is associated with both plasma CETP and HDL-C levels and with premature CAD. Such associations appear to result from linkage disequilibrium (LD) between TaqIB and other functional polymorphisms. To date only one functional promoter variant that may explain the effects of TaqIB has been identified at position -629 in the CETP gene. Here we describe a C/T polymorphism located at position -1337 in the human CETP gene (C allele frequency: 0.684) which is significantly associated with both plasma HDL-C and CETP levels (p = 0.0001 and p < .0001, respectively). Transient transfection of a reporter gene construct containing the CETP promoter from -1707/+28 in liver cells (HepG2) revealed that the -1337T allele was expressed to a significantly lower degree (-34%, p < .0001) than the -1337C allele. In addition, we clearly demonstrated that the -971G/A polymorphism is functional, and that its functionality is intimately linked to the presence of the -1337 site. In vitro evaluation of potential interaction between -1337C/T and other functional variants of the CETP gene (-971G/A and -629C/A) demonstrated that these three functional CETP promoter polymorphisms can interact together to determine the overall activity of the CETP gene and thus contribute significantly to variation in plasma CETP mass concentration.
Received June 2, 2005
Revised July 12, 2005
Accepted July 20, 2005
Article
Functional Interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study
2 Department of Vascular Medicine, AMC, Amsterdam, The Netherlands
3 Department of Clinical Epidemiology and Biostatistics, AMC, Amsterdam, The Netherlands
4 Department of Cardiology, LUMC, Leiden, The Netherlands
5 INSERM Unité 551, «Dyslipoproteinemia and Atherosclerosis», Hôpital de la Pitié, Pavillon Benjamin Delessert, 83, boulevard de l'Hôpital, 75651 Paris Cedex 13, France
Maryse Guerin, E-mail: mguerin{at}chups.jussieu.fr
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. Sauter, A. Rosenberger, L. Beckmann, S. Kropp, K. Mittelstrass, M. Timofeeva, G. Wolke, A. Steinwachs, D. Scheiner, E. Meese, et al. Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1127 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Jensen, K. J. Mukamal, K. Overvad, and E. B. Rimm Alcohol consumption, TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and women Eur. Heart J., January 1, 2008; 29(1): 104 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Spielmann, A. S. Leon, D. C. Rao, T. Rice, J. S. Skinner, C. Bouchard, and T. Rankinen CETP genotypes and HDL-cholesterol phenotypes in the HERITAGE Family Study Physiol Genomics, September 11, 2007; 31(1): 25 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kyriakou, D. E. Pontefract, E. Viturro, C. P. Hodgkinson, R. C. Laxton, N. Bogari, G. Cooper, M. Davies, J. Giblett, I. N.M. Day, et al. Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients Hum. Mol. Genet., June 15, 2007; 16(12): 1412 - 1422. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Horne, N. J. Camp, J. L. Anderson, C. P. Mower, J. L. Clarke, M. J. Kolek, J. F. Carlquist, and for the Intermountain Heart Collaborative Study Gr Multiple Less Common Genetic Variants Explain the Association of the Cholesteryl Ester Transfer Protein Gene With Coronary Artery Disease J. Am. Coll. Cardiol., May 22, 2007; 49(20): 2053 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. van der Steeg, G. K. Hovingh, A. H. E. M. Klerkx, B. A. Hutten, I. C. Nootenboom, J. H. M. Levels, A. van Tol, G. M. Dallinga-Thie, A. H. Zwinderman, J. J. P. Kastelein, et al. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians J. Lipid Res., March 1, 2007; 48(3): 674 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Pearce, R. C. Laxton, A. C. Pereira, and S. Ye Haplotype Effects on Matrix Metalloproteinase-1 Gene Promoter Activity in Cancer Cells Mol. Cancer Res., March 1, 2007; 5(3): 221 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Thompson, L. S. Wood, E. H. Pickering, B. DeChairo, and C. L. Hyde High-density genotyping and functional SNP localization in the CETP gene J. Lipid Res., February 1, 2007; 48(2): 434 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T.E. Wootton, F. Drenos, J. A. Cooper, S. R. Thompson, J. W. Stephens, E. Hurt-Camejo, O. Wiklund, S. E. Humphries, and P. J. Talmud Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study Hum. Mol. Genet., January 15, 2006; 15(2): 355 - 361. [Abstract] [Full Text] [PDF] |
||||






